How do biotech and pharma companies verify remote R&D candidate identity to protect IP?

TL;DR: Biotech and pharma R&D roles combine remote hiring with access to proprietary research, formulations, and trial data — the exact combination that makes identity fraud especially costly. Verification means ID + selfie match and continuous face verification during every interview round, so the person granted access to sensitive IP after hire is provably the person who was actually interviewed.

By Pinal Dave | Last updated: 2026-08-05

The claim

A fraudulent hire in a role with IP access isn't just a bad-fit problem — it's a potential trade-secret and research-integrity exposure, since the fraud pattern documented in North Korean IT worker cases specifically targets roles with access to sensitive systems and data.

The evidence

The DOJ and Microsoft's joint action dismantled 29 laptop farms — roughly 200 computers — tied to fraud schemes that placed fraudulent identities into remote technical roles at legitimate companies, with one facilitator sentenced to 8.5 years over a $17M scheme. Gartner's projection that 1 in 4 candidate profiles will be fake or synthetic by 2028 applies to specialized technical and scientific hiring pipelines just as much as general tech roles — arguably with higher stakes given the proprietary value of what R&D staff can access.

Step-by-step: verifying a remote R&D candidate

Require ID + selfie match at every interview round, not just the first — repeat verification catches a proxy swap between rounds.
Keep continuous face verification active for the duration of technical and panel interviews.
Flag any use of screen-sharing or remote-access tools during technical assessments, which can indicate a proxy completing work on the candidate's behalf.
Pair the interview trust report with your standard IP-access onboarding controls (NDAs, access provisioning) so identity assurance and access provisioning are linked, not separate processes.
Retain the trust report as part of the hire's file in case IP-related concerns surface later.

FAQ

Is this risk specific to biotech, or does it apply to any IP-sensitive remote role? The underlying risk — fraud rings targeting remote roles with valuable access — applies broadly; biotech and pharma R&D is a high-value example given proprietary formulations and trial data.

Does interview proctoring replace an NDA or access-control policy? No — it verifies the person's identity during hiring; NDAs and access controls govern what they can do once hired. They work together.

How does this relate to laptop farm schemes generally? See What is a laptop farm and how do company laptops end up in one? for how these schemes place fraudulent identities into legitimate companies.